更正：埃拉洛夫等人。基于生物信息学的mRNA疫苗设计用于控制由……引起的股癣。2024年，……，983。

1

Pharmaceutics. 2024 Sep 29;16(10):1273. doi: 10.3390/pharmaceutics16101273.

2

Pharmaceutics. 2024 Jul 25;16(8):983. doi: 10.3390/pharmaceutics16080983.

3

Rev Iberoam Micol. 2008 Dec 31;25(4):250-3. doi: 10.1016/s1130-1406(08)70059-7.

4

J Dermatol. 2012 Dec;39(12):1000-1. doi: 10.1111/j.1346-8138.2012.01635.x. Epub 2012 Aug 20.

5

Br J Dermatol. 2005 Jul;153(1):178-82. doi: 10.1111/j.1365-2133.2005.06615.x.

6

Mykosen. 1972 Jun 1;15(6):245-8. doi: 10.1111/j.1439-0507.1972.tb02502.x.

7

Indian J Dermatol Venereol Leprol. 1996 Jul-Aug;62(4):210-2.

8

Mycopathologia. 2002;153(1):29-31. doi: 10.1023/a:1015257320824.

9

Indian Dermatol Online J. 2021 Sep 10;12(5):714-721. doi: 10.4103/idoj.IDOJ_909_20. eCollection 2021 Sep-Oct.

10

Mycoses. 1996 Jan-Feb;39(1-2):31-5. doi: 10.1111/j.1439-0507.1996.tb00080.x.

Correction: Elalouf et al. Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by . 2024, , 983.